Ocuphire Pharma Investor Presentation — March 2021

Document content

Restore Vision & Clarity

Ocuphire Corporate Presentation

March 10, 2021Mina Sooch CEO2

Disclosures and Forward Looking Statements

This presentation contains “forward -looking statements” within the meaning of the Private Securities Litigation

Reform Act of 1995. Such statements include, but are not limited to, statements concerning Ocuphire Pharma,

Inc.’s (“Ocuphire” or the “Company”) product candidates and potential. These forward -looking statements are

based upon the Company’s current expectations and involve assumptions that may never materialize or may

prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in

such forward -looking statements as a result of various risks and uncertainties, including, without limitation: (i)

potential adverse reactions or changes to business relationships resulting from the announcement or completion

of the merger; (ii) the success and timing of regulatory submissions and pre -clinical and clinical trials; (iii)

regulatory requirements or developments; (iv) changes to clinical trial designs and regulatory pathways; (v)

changes in capital resource requirements; (vi) risks related to the inability of the Company to obtain sufficient

additional capital to continue to advance its product candidates and its preclinical programs; (vii) legislative,

regulatory, political and economic developments, and (viii) the effects of COVID -19 on clinical programs and

business operations. The foregoing review of important factors that could cause actual events to differ from

expectations should not be construed as exhaustive and should be read in conjunction with statements that are

included herein and elsewhere, including the risk factors detailed in documents that have been and may be filed

by the Company from time to time with the SEC. All forward -looking statements contained in this presentation

speak only as of the date on which they were made. The Company undertakes no obligation to update such

statements to reflect events that occur or circumstances that exist after the date on which they were made.

The Company makes no representation or warranty, express or implied, as to the accuracy or completeness of

the information contained in or incorporated by reference into this presentation. Nothing contained in or

incorporated by reference into this presentation is, or shall be relied upon as, a promise or representation by the

Company as to the past or future. The Company assumes no responsibility for the accuracy or completeness of